Last Price$33.90.6%
Market Cap$15.2B
14.5%
Industry median - (83.9%)
5Y Historical average - 138.7%
6.7%
Industry median - (90.6%)
5Y Historical average - 134.2%
0.0%
Industry median - (33.9%)
5Y Historical average - 11.1%
6.2%
Industry median - (34.0%)
5Y Historical average - 6.6%
RPRX Capital Allocation Rating
RPRX Capital Allocation rating
5.1
RPRX Capital Allocation rating performance
RPRX Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with RPRX Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$15.2B | 5.1 | 14.5% | 6.7% | 37.0% | 0.0% | 6.2% | (2.8%) | 3.6% | |
$402.0B | 6.1 | 35.5% | 28.0% | 24.3% | 76.5% | 46.8% | (1.0%) | 2.2% | |
$125.5B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$74.0B | 6.2 | 25.0% | 17.4% | 24.6% | 13.7% | 10.3% | 1.4% | 4.3% | |
$38.1B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$31.3B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$27.1B | 5.2 | (41.4%) | (48.4%) | 37.5% | (1.7%) | (5.5%) | (0.8%) | 0.0% | |
$14.8B | 4.9 | (12.7%) | (20.5%) | 13.4% | 1.0% | (6.1%) | (14.1%) | 13.6% | |
$14.6B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$14.0B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.2% | |
$1,846.9M | 4.3 | (38.4%) | (45.1%) | (41.5%) | (25.3%) | (24.7%) | 0.0% | 0.0% |
FAQ
What is the Royalty Pharma plc (RPRX) ROIC (Return on Invested Capital)?
The Royalty Pharma plc (RPRX) ROIC is 14.5%, compared to the industry median of ((83.9%)) and the 5-year historical average of 138.7%.
What is the Royalty Pharma plc (RPRX) ROIC minus WACC (Weighted Average Cost of Capital)?
The Royalty Pharma plc (RPRX) ROIC minus WACC is 6.7%, compared to the industry median of ((90.6%)) and the 5-year historical average of 134.2%.
What is the Royalty Pharma plc (RPRX) ROE (Return on Equity)?
The Royalty Pharma plc (RPRX) ROE is 0.0%, compared to the industry median of ((33.9%)) and the 5-year historical average of 11.1%.
What is the Royalty Pharma plc (RPRX) ROCE (Return on Capital Employed)?
The Royalty Pharma plc (RPRX) ROCE is 6.2%, compared to the industry median of ((34.0%)) and the 5-year historical average of 6.6%.